Cassava Sciences | PTIE - Trade Creditors


Cassava Sciences reported $39.19M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Amgen USD 2.86B 16.65B Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
Cara Therapeutics USD 4.62M 1.4M Mar/2026
Cassava Sciences USD 39.19M 2.46M Mar/2026
Eisai JPY 87.53B 11.64B Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Geron USD 8.8M 3.92M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Merck USD 3.83B 36M Jun/2026
Novartis USD 4.26B 64M Jun/2026
Novavax USD 22.94M 6.84M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026